Vicadrostat is under clinical development by Boehringer Ingelheim International and currently in Phase III for Chronic Kidney Disease (Chronic Renal Failure).
Calls for humanitarian pause to safeguard polio vaccination efforts in Gaza
Two rounds of a polio vaccination campaign are expected to be launched at the end of August and September 2024 across the Gaza Strip to